BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laurell G, Jungnelius U. High-dose cisplatin treatment: hearing loss and plasma concentrations. Laryngoscope. 1990;100:724-734. [PMID: 2362532 DOI: 10.1288/00005537-199007000-00008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Pauzi AZ, Yeap SK, Abu N, Lim KL, Omar AR, Aziz SA, Chow AL, Subramani T, Tan SG, Alitheen NB. Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin Med 2016;11:46. [PMID: 27891174 DOI: 10.1186/s13020-016-0118-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
2 Li G, Frenz DA, Brahmblatt S, Feghali JG, Ruben RJ, Berggren D, Arezzo J, Van De Water TR. Round Window Membrane Delivery of l-Methionine Provides Protection from Cisplatin Ototoxicity Without Compromising Chemotherapeutic Efficacy. NeuroToxicology 2001;22:163-76. [DOI: 10.1016/s0161-813x(00)00010-3] [Cited by in Crossref: 76] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
3 Kwon YJ, Jung JJ, Park NH, Ye DJ, Kim D, Moon A, Chun YJ. Annexin a5 as a new potential biomarker for Cisplatin-induced toxicity in human kidney epithelial cells. Biomol Ther (Seoul). 2013;21:190-195. [PMID: 24265863 DOI: 10.4062/biomolther.2013.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
4 Moon HH, Seo KW, Yoon KY, Shin YM, Choi KH, Lee SH. Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients. World J Gastroenterol 2011; 17(30): 3510-3517 [PMID: 21941418 DOI: 10.3748/wjg.v17.i30.3510] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Naples JG, Parham K. Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model. Otolaryngol Head Neck Surg 2016;154:144-9. [DOI: 10.1177/0194599815606704] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Niihori M, Platto T, Igarashi S, Hurbon A, Dunn AM, Tran P, Tran H, Mudery JA, Slepian MJ, Jacob A. Zebrafish swimming behavior as a biomarker for ototoxicity-induced hair cell damage: a high-throughput drug development platform targeting hearing loss. Translational Research 2015;166:440-50. [DOI: 10.1016/j.trsl.2015.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
7 Li J, Lyv Z, Li Y, Liu H, Wang J, Zhan W, Chen H, Chen H, Li X. A theranostic prodrug delivery system based on Pt(IV) conjugated nano-graphene oxide with synergistic effect to enhance the therapeutic efficacy of Pt drug. Biomaterials 2015;51:12-21. [PMID: 25770993 DOI: 10.1016/j.biomaterials.2015.01.074] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 12.8] [Reference Citation Analysis]
8 Laurell GFE. Combined Effects of Noise and Cisplatin: Short- and Long-Term Follow-Up. Ann Otol Rhinol Laryngol 1992;101:969-76. [DOI: 10.1177/000348949210101202] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
9 Li Y, Womer R, Silber J. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. European Journal of Cancer 2004;40:2445-51. [DOI: 10.1016/j.ejca.2003.08.009] [Cited by in Crossref: 237] [Cited by in F6Publishing: 209] [Article Influence: 13.9] [Reference Citation Analysis]
10 Laurell G, Bagger-sjöbäck D. Degeneration of the Organ of Corti Following Intravenous Administration of Cisplatin. Acta Oto-Laryngologica 2009;111:891-8. [DOI: 10.3109/00016489109138427] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
11 Reavis KM, McMillan G, Austin D, Gallun F, Fausti SA, Gordon JS, Helt WJ, Konrad-Martin D. Distortion-product otoacoustic emission test performance for ototoxicity monitoring. Ear Hear 2011;32:61-74. [PMID: 20625302 DOI: 10.1097/AUD.0b013e3181e8b6a7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
12 Sluyter S, Klis SF, de Groot JC, Smoorenburg GF. Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 2003;185:49-56. [PMID: 14599692 DOI: 10.1016/s0378-5955(03)00260-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
13 Lanvers-Kaminsky C, Krefeld B, Dinnesen AG, Deuster D, Seifert E, Würthwein G, Jaehde U, Pieck AC, Boos J. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters. Pediatr Blood Cancer 2006;47:183-93. [PMID: 16302218 DOI: 10.1002/pbc.20673] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
14 Lewis MJ, DuBois SG, Fligor B, Li X, Goorin A, Grier HE. Ototoxicity in children treated for osteosarcoma. Pediatr Blood Cancer 2009;52:387-91. [PMID: 19061216 DOI: 10.1002/pbc.21875] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
15 Myers SF, Blakley BW, Schwan S. Is cis-platinum vestibulotoxic? Otolaryngol Head Neck Surg 1993;108:322-8. [PMID: 8483602 DOI: 10.1177/019459989310800403] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
16 Esfahani Monfared Z, Khosravi A, Safavi Naini A, Radmand G, Khodadad K. Analysis of Cisplatin-Induced Ototoxicity Risk Factors in Iranian Patients with Solid Tumors: a Cohort, Prospective and Single Institute Study. Asian Pac J Cancer Prev 2017;18:753-8. [PMID: 28441710 DOI: 10.22034/APJCP.2017.18.3.753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Bernhardson BM, Tishelman C, Rutqvist LE. Olfactory changes among patients receiving chemotherapy. Eur J Oncol Nurs 2009;13:9-15. [PMID: 19028142 DOI: 10.1016/j.ejon.2008.10.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
18 Güneri EA, Şerbetçioğlu B, İkiz AÖ, Güneri A, Ceryan K. TEOAE monitoring of Cisplatin induced ototoxicity in guinea pigs: the protective effect of vitamin B treatment. Auris Nasus Larynx 2001;28:9-14. [DOI: 10.1016/s0385-8146(00)00056-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dhar S, Daniel WL, Giljohann DA, Mirkin CA, Lippard SJ. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc 2009;131:14652-3. [PMID: 19778015 DOI: 10.1021/ja9071282] [Cited by in Crossref: 383] [Cited by in F6Publishing: 352] [Article Influence: 34.8] [Reference Citation Analysis]
20 Hattis D. Variability in susceptibility — how big, how often, for what responses to what agents? Environmental Toxicology and Pharmacology 1996;2:135-45. [DOI: 10.1016/s1382-6689(96)00044-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Hoistad DL, Ondrey FG, Mutlu C, Schachern PA, Paparella MM, Adams GL. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg 1998;118:825-32. [PMID: 9627244 DOI: 10.1016/S0194-5998(98)70276-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Laurell G, Beskow C, Frankendal B, Borg E. Cisplatin administration to gynecologic cancer patients: Long term effects on hearing. Cancer 1996;78:1798-804. [DOI: 10.1002/(sici)1097-0142(19961015)78:8<1798::aid-cncr22>3.0.co;2-s] [Cited by in Crossref: 14] [Article Influence: 0.6] [Reference Citation Analysis]
23 Petrioli R, Frediani B, Manganelli A, Barbanti G, De Capua B, De Lauretis A, Salvestrini F, Mondillo S, Francini G. Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study. Cancer 1996;77:344-51. [PMID: 8625244 DOI: 10.1002/(SICI)1097-0142(19960115)77:2<344::AID-CNCR18>3.0.CO;2-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
24 Eroğlu O, Karlıdağ T, Kuloğlu T, Keleş E, Kaygusuz İ, Yalçın Ş. The Protective Effect of Cortexin on Cisplatin-Induced Ototoxicity. J Int Adv Otol 2018;14:27-33. [PMID: 29092803 DOI: 10.5152/iao.2017.3825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Ekborn A, Laurell G, Ehrsson H, Miller J. Intracochlear administration of thiourea protects against cisplatin-induced outer hair cell loss in the guinea pig. Hear Res 2003;181:109-15. [PMID: 12855369 DOI: 10.1016/s0378-5955(03)00181-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
26 Samocha-Bonet D, Wu B, Ryugo DK. Diabetes mellitus and hearing loss: A review. Ageing Res Rev 2021;71:101423. [PMID: 34384902 DOI: 10.1016/j.arr.2021.101423] [Reference Citation Analysis]
27 Gündoğdu R, Erkan M, Aydın M, Sönmez MF, Vural A, Kökoğlu K, Karabulut D, Şahin Mİ. Assessment of the Effectiveness of Quercetin on Cisplatin-Induced Ototoxicity in Rats. J Int Adv Otol 2019;15:229-36. [PMID: 31287434 DOI: 10.5152/iao.2019.5902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Hattis D, Banati JP, Goble R, Burmaster DE. Human Interindividual Variability in Parameters Related to Health Risks. Risk Analysis 1999;19:711-26. [DOI: 10.1111/j.1539-6924.1999.tb00441.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
29 Sepmeijer JW, Klis SF. Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig. Hearing Research 2009;247:34-9. [DOI: 10.1016/j.heares.2008.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
30 Waterhouse DM, Reynolds RK, Natale RB. Combined carboplatin and cisplatin. Limited Prospects for Dose Intensification. Cancer 1993;71:4060-6. [DOI: 10.1002/1097-0142(19930615)71:12<4060::aid-cncr2820711242>3.0.co;2-0] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
31 Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol 1996;26:95-100. [DOI: 10.1002/(sici)1096-911x(199602)26:2<95::aid-mpo5>3.0.co;2-p] [Cited by in Crossref: 38] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Castro-ramírez R, Ortiz-pastrana N, Caballero AB, Zimmerman MT, Stadelman BS, Gaertner AAE, Brumaghim JL, Korrodi-gregório L, Pérez-tomás R, Gamez P, Barba-behrens N. DNA interactions of non-chelating tinidazole-based coordination compounds and their structural, redox and cytotoxic properties. Dalton Trans 2018;47:7551-60. [DOI: 10.1039/c8dt00716k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Blakley BW, Myers SF. Patterns of hearing loss resulting from cis-platinum therapy. Otolaryngol Head Neck Surg 1993;109:385-91. [PMID: 8414553 DOI: 10.1177/019459989310900302] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
34 Dauman R, Dulon D. Ototoxicidad medicamentosa. EMC - Otorrinolaringología 2000;29:1-12. [DOI: 10.1016/s1632-3475(00)71950-3] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
35 Yorgason JG, Fayad JN, Kalinec F. Understanding drug ototoxicity: molecular insights for prevention and clinical management. Expert Opinion on Drug Safety 2006;5:383-99. [DOI: 10.1517/14740338.5.3.383] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
36 Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D. Development and validation of a cisplatin dose-ototoxicity model. J Am Acad Audiol 2012;23:510-21. [PMID: 22992258 DOI: 10.3766/jaaa.23.7.3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
37 Hill GW, Morest DK, Parham K. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections. Otol Neurotol 2008;29:1005-11. [PMID: 18716567 DOI: 10.1097/MAO.0b013e31818599d5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
38 Garcia AP, Iório MCM, Petrilli AS. Monitoramento da audição de pacientes expostos à cisplatina. Rev Bras Otorrinolaringol 2003;69:215-21. [DOI: 10.1590/s0034-72992003000200011] [Cited by in Crossref: 19] [Article Influence: 1.1] [Reference Citation Analysis]
39 Sockalingam R, Charles B, Filippich L, Murdoch B. Cisplatin-Induced Ototoxicity and Pharmacokinetics: Preliminary Findings in a Dog Model. Ann Otol Rhinol Laryngol 2002;111:745-50. [DOI: 10.1177/000348940211100816] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
40 Schacht J, Talaska AE, Rybak LP. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken). 2012;295:1837-1850. [PMID: 23045231 DOI: 10.1002/ar.22578] [Cited by in Crossref: 188] [Cited by in F6Publishing: 171] [Article Influence: 20.9] [Reference Citation Analysis]
41 Hellberg V, Wallin I, Ehrsson H, Laurell G. Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig. Laryngoscope 2013;123:3172-7. [PMID: 23754209 DOI: 10.1002/lary.24235] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
42 Lorito G, Hatzopoulos S, Laurell G, Campbell KC, Petruccelli J, Giordano P, Kochanek K, Sliwa L, Martini A, Skarzynski H. Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model. Med Sci Monit 2011;17:BR179-186. [PMID: 21804453 DOI: 10.12659/msm.881894] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
43 McKeage MJ. Comparative adverse effect profiles of platinum drugs. Drug Saf 1995;13:228-44. [PMID: 8573296 DOI: 10.2165/00002018-199513040-00003] [Cited by in Crossref: 208] [Cited by in F6Publishing: 194] [Article Influence: 8.3] [Reference Citation Analysis]
44 Skjonsberg A, Bucinskaite V, Laurell G, Ulfendahl M. Augmented ototoxic effect of cisplatin in heterozygotes of the German waltzing guinea pig. Audiol Neurootol 2008;13:97-104. [PMID: 18057873 DOI: 10.1159/000111781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR. Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hearing Research 2003;182:56-64. [DOI: 10.1016/s0378-5955(03)00142-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
46 Yorgason JG, Luxford W, Kalinec F. In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem. Expert Opin Drug Metab Toxicol 2011;7:1521-34. [PMID: 21999330 DOI: 10.1517/17425255.2011.614231] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
47 Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi B. The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. International Journal of Audiology 2009;43:465-70. [DOI: 10.1080/14992020400050059] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
48 Duan ML, Ulfendahl M, Laurell G, Counter SA, Pyykkö I, Borg E, Rosenhall U. Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application. Hear Res 2002;169:169-78. [PMID: 12121749 DOI: 10.1016/s0378-5955(02)00484-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
49 Minami SB, Sha S, Schacht J. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hearing Research 2004;198:137-43. [DOI: 10.1016/j.heares.2004.07.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
50 Li G, Sha S, Zotova E, Arezzo J, Van De Water T, Schacht J. Salicylate Protects Hearing and Kidney Function from Cisplatin Toxicity without Compromising its Oncolytic Action. Lab Invest 2002;82:585-96. [DOI: 10.1038/labinvest.3780453] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 3.6] [Reference Citation Analysis]
51 Klis SF, O’leary SJ, Wijbenga J, de Groot JC, Hamers FP, Smoorenburg GF. Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose. Hearing Research 2002;164:138-46. [DOI: 10.1016/s0378-5955(01)00425-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
52 Tate AD, Antonelli PJ, Hannabass KR, Dirain CO. Mitochondria-Targeted Antioxidant Mitoquinone Reduces Cisplatin-Induced Ototoxicity in Guinea Pigs. Otolaryngol Head Neck Surg 2017;156:543-8. [PMID: 28248600 DOI: 10.1177/0194599816678381] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
53 Laurell G, Teixeira M, Sterkers O, Ferrary E. Paracellular transport properties of inner ear barriers do not account for cisplatin toxicity in the rat. Hearing Research 1997;110:135-40. [DOI: 10.1016/s0378-5955(97)00067-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Alkureishi LW, de Bree R, Ross GL. RADPLAT: an alternative to surgery? Oncologist. 2006;11:469-480. [PMID: 16720847 DOI: 10.1634/theoncologist.11-5-469] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
55 Hatzopoulos S, Petruccelli J, Laurell G, Avan P, Finesso M, Martini A. Ototoxic effects of cisplatin in a Sprague-Dawley rat animal model as revealed by ABR and transiently evoked otoacoustic emission measurements. Hear Res 2002;170:70-82. [PMID: 12208542 DOI: 10.1016/s0378-5955(02)00453-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Berg AL, Spitzer JB, Garvin JH. Ototoxic Impact of Cisplatin in Pediatric Oncology Patients. Laryngoscope 1999;109:1806-14. [DOI: 10.1097/00005537-199911000-00016] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
57 Sooriyaarachchi M, Gibson MA, Lima BDS, Gailer J. Modulation of the metabolism of cis -platin in blood plasma by glutathione. Can J Chem 2016;94:360-6. [DOI: 10.1139/cjc-2015-0395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
58 Stöhr W, Langer T, Kremers A, Bielack S, Lamprecht-dinnesen A, Frey E, Beck JD. Cisplatin-Induced Ototoxicity in Osteosarcoma Patients: A Report from the Late Effects Surveillance System. Cancer Investigation 2009;23:201-7. [DOI: 10.1081/cnv-200055951] [Cited by in Crossref: 50] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
59 Dutta A, Venkatesh MD, Kashyap RC. Study of the effects of chemotherapy on auditory function. Indian J Otolaryngol Head Neck Surg 2005;57:226-8. [PMID: 23120177 DOI: 10.1007/BF03008019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
60 Arslan E, Orzan E, Santarelli R. Global problem of drug-induced hearing loss. Ann N Y Acad Sci 1999;884:1-14. [PMID: 10842579 DOI: 10.1111/j.1749-6632.1999.tb00277.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
61 Todd NW, Alvarado CS, Brewer DB. Cisplatin in children: hearing loss correlates with iris and skin pigmentation. J Laryngol Otol 1995;109:926-9. [DOI: 10.1017/s002221510013169x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
62 Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission. Oncology 2006;70:177-84. [PMID: 16757924 DOI: 10.1159/000093776] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
63 O'Leary SJ, Klis SF, de Groot JC, Hamers FP, Smoorenburg GF. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects. Hear Res 2001;154:135-45. [PMID: 11423224 DOI: 10.1016/s0378-5955(01)00232-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
64 Yakirevitch A, Talmi YP, Baram Y, Weitzen R, Pfeffer MR. Effects of cisplatin on olfactory function in cancer patients. Br J Cancer 2005;92:1611-3. [PMID: 15827551 DOI: 10.1038/sj.bjc.6602544] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
65 Johnson A, Canlon B. Toluene exposure affects the functional activity of the outer hair cells. Hearing Research 1994;72:189-96. [DOI: 10.1016/0378-5955(94)90218-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
66 Ekborn A, Hansson J, Ehrsson H, Eksborg S, Wallin I, Wagenius G, Laurell G. High-Dose Cisplatin With Amifostine: Ototoxicity and Pharmacokinetics: . The Laryngoscope 2004;114:1660-7. [DOI: 10.1097/00005537-200409000-00030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
67 Miettinen S, Laurell G, Andersson A, Johansson R, Laurikainen E. Blood Flow-independent Accumulation of Cisplatin in the Guinea Pig Cochlea. Acta Oto-Laryngologica 2009;117:55-60. [DOI: 10.3109/00016489709117992] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
68 Sooriyaarachchi M, White WM, Narendran A, Gailer J. Chemoprotection by d -methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma. Metallomics 2014;6:532-41. [DOI: 10.1039/c3mt00238a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 2.9] [Reference Citation Analysis]
69 Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Schornagel JH, Dreschler WA, Rasch CR, Balm AJ. Ototoxicity in a Randomized Phase III Trial of Intra-Arterial Compared With Intravenous Cisplatin Chemoradiation in Patients With Locally Advanced Head and Neck Cancer. JCO 2007;25:3759-65. [DOI: 10.1200/jco.2006.08.9540] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
70 Laurell G, Teixeira M, Sterkers O, Ferrary E. Effect of cisplatin administration on the electrochemical composition of endolymph in the rat cochlea. Hearing Research 1995;87:16-20. [DOI: 10.1016/0378-5955(95)00074-e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Schweitzer VG. Cisplatin-Induced Ototoxicity: The Effect of Pigmentation and Inhibitory Agents. The Laryngoscope 1993;103:1-52. [DOI: 10.1002/lary.1993.103.s59.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Riga MG, Chelis L, Kakolyris S, Papadopoulos S, Stathakidou S, Chamalidou E, Xenidis N, Amarantidis K, Dimopoulos P, Danielides V. Transtympanic Injections of N-acetylcysteine for the Prevention of Cisplatin-induced Ototoxicity: A Feasible Method With Promising Efficacy. American Journal of Clinical Oncology 2013;36:1-6. [DOI: 10.1097/coc.0b013e31822e006d] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 7.1] [Reference Citation Analysis]
73 Planting AS, Catimel G, de Mulder PH, de Graeff A, Höppener F, Verweij J, Oster W, Vermorken JB. Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group. Ann Oncol 1999;10:693-700. [PMID: 10442192 DOI: 10.1023/a:1008353505916] [Cited by in Crossref: 71] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
74 Riedemann L, Lanvers C, Deuster D, Peters U, Boos J, Jürgens H, Zehnhoff-dinnesen AA. Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Pharmacogenomics J 2008;8:23-8. [DOI: 10.1038/sj.tpj.6500455] [Cited by in Crossref: 86] [Cited by in F6Publishing: 67] [Article Influence: 6.1] [Reference Citation Analysis]
75 Peters R, Mommersteeg P, Heijmen P. The electroreceptor organ of the catfish, Ictalurus melas, as a model for cisplatin-induced ototoxicity. Neuroscience 1999;91:745-51. [DOI: 10.1016/s0306-4522(98)00658-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Sooriyaarachchi M, Narendran A, Gailer J. N-Acetyl-l-cysteine modulates the metabolism of cis-platin in human plasma in vitro. Metallomics 2013;5:197. [DOI: 10.1039/c3mt00012e] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
77 Schweitzer VG. Ototoxicity of Chemotherapeutic Agents. Otolaryngologic Clinics of North America 1993;26:759-89. [DOI: 10.1016/s0030-6665(20)30766-0] [Cited by in Crossref: 71] [Article Influence: 2.5] [Reference Citation Analysis]
78 Morata TC, Johnson A. Effects of Exposure to Chemicals on Noise-Induced Hearing Loss. In: Le Prell CG, Henderson D, Fay RR, Popper AN, editors. Noise-Induced Hearing Loss. New York: Springer; 2012. pp. 223-54. [DOI: 10.1007/978-1-4419-9523-0_11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Laurell G, Andersson A, Engström B, Ehrsson H. Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig. Cancer Chemother Pharmacol 1995;36:83-6. [PMID: 7720182 DOI: 10.1007/BF00685738] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
80 Punnett A, Bliss B, Dupuis LL, Abdolell M, Doyle J, Sung L. Ototoxicity following pediatric hematopoietic stem cell transplantation: A prospective cohort study. Pediatr Blood Cancer 2004;42:598-603. [DOI: 10.1002/pbc.20036] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
81 Sie KCY, Norton SJ. Changes in Otoacoustic Emissions and Auditory Brain Stem Response after C/s-Platinum Exposure in Gerbils. Otolaryngol Head Neck Surg 1997;116:585-92. [DOI: 10.1016/s0194-5998(97)70232-8] [Cited by in Crossref: 15] [Article Influence: 5.0] [Reference Citation Analysis]
82 De Freitas MR, Almeida Figueiredo A, de Castro Brito GA, de Carvalho Leitao RF, de Carvalho JV, Gomes RM, de Albuquerque Ribeiro R. The role of apoptosis in cisplatin-induced ototoxicity in rats. Brazilian Journal of Otorhinolaryngology 2009;75:745-52. [DOI: 10.1016/s1808-8694(15)30528-0] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
83 Hatzopoulos S, Stefano MD, Campbell KCM, Falgione D, Ricci D, Rosignoli M, Finesso M, Albertin A, Previati M, Capitani S, Martini A. Cisplatin Ototoxicity in the Sprague Dawley Rat Evaluated by Distortion Product Otoacoustic Emissions:Ototoxicidad por Cisplatino en la rata Sprague Dawley evaluada mediante productos de distorsión de las emisiones otoacústicas. Int J Audiol 2001;40:253-64. [DOI: 10.3109/00206090109073119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
84 Nitz A, Kontopantelis E, Bielack S, Koscielniak E, Klingebiel T, Langer T, Paulides M. Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients. Oncol Lett 2013;5:311-5. [PMID: 23255940 DOI: 10.3892/ol.2012.997] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
85 Truong MT, Winzelberg J, Chang KW. Recovery from cisplatin-induced ototoxicity: a case report and review. Int J Pediatr Otorhinolaryngol 2007;71:1631-8. [PMID: 17706797 DOI: 10.1016/j.ijporl.2007.06.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
86 Laurell G, Videhult Pierre P. Hearing Loss After Cisplatin: Oxidative Stress Pathways and Potential for Protection. In: Miller J, Le Prell CG, Rybak L, editors. Free Radicals in ENT Pathology. Cham: Springer International Publishing; 2015. pp. 217-41. [DOI: 10.1007/978-3-319-13473-4_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
87 de Jongh FE, van Veen RN, Veltman SJ, de Wit R, van der Burg ME, van den Bent MJ, Planting AS, Graveland WJ, Stoter G, Verweij J. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer 2003;88:1199-206. [PMID: 12698184 DOI: 10.1038/sj.bjc.6600884] [Cited by in Crossref: 143] [Cited by in F6Publishing: 130] [Article Influence: 8.4] [Reference Citation Analysis]
88 Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH, Dreschler WA, Balm AJ. Risk Factors of Ototoxicity After Cisplatin-Based Chemo-Irradiation in Patients With Locally Advanced Head-and-Neck Cancer: A Multivariate Analysis. International Journal of Radiation Oncology*Biology*Physics 2007;68:1320-5. [DOI: 10.1016/j.ijrobp.2007.01.042] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
89 Rubin JS, Wadler S, Baitler JJ, Haynes H, Rozenblet A, Mcgill F, Goldberg G, Runowicz C. Audiological findings in a Phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma. J Laryngol Otol 1995;109:744-7. [DOI: 10.1017/s0022215100131202] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
90 De Lauretis A, De Capua B, Barbieri MT, Bellussi L, Passàli D. ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin. Scand Audiol 1999;28:139-43. [PMID: 10489862 DOI: 10.1080/010503999424707] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
91 Todd DW, Philip RC, Niihori M, Ringle RA, Coyle KR, Zehri SF, Zabala L, Mudery JA, Francis RH, Rodriguez JJ, Jacob A. A Fully Automated High-Throughput Zebrafish Behavioral Ototoxicity Assay. Zebrafish 2017;14:331-42. [PMID: 28520533 DOI: 10.1089/zeb.2016.1412] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
92 Li Y, Ding D, Jiang H, Fu Y, Salvi R. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice. Neurotox Res 2011;20:307-19. [PMID: 21455790 DOI: 10.1007/s12640-011-9244-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
93 Rybak LP. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Current Opinion in Otolaryngology & Head & Neck Surgery 2007;15:364-9. [DOI: 10.1097/moo.0b013e3282eee452] [Cited by in Crossref: 125] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
94 Hughes AL, Hussain N, Pafford R, Parham K. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model. Otolaryngol Head Neck Surg 2014;150:115-20. [PMID: 24233060 DOI: 10.1177/0194599813511948] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
95 Park KR. The Utility of Acoustic Reflex Thresholds and Other Conventional Audiologic Tests for Monitoring Cisplatin Ototoxicity in the Pediatric Population: . Ear and Hearing 1996;17:107-15. [DOI: 10.1097/00003446-199604000-00003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]